PIK3CA and oligodendroglioma: Patient 16 with an oligodendroglioma, IDH-mutant and 1p/19q codeleted (CNS WHO grade 3) with an activating PIK3CA mutation was treated with the PIK3CA inhibitor alpelisib (allele frequency of PIK3CA mutation 33%).